211 related articles for article (PubMed ID: 16259944)
21. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway.
Vlachos P; Nyman U; Hajji N; Joseph B
Cell Death Differ; 2007 Aug; 14(8):1497-507. PubMed ID: 17464323
[TBL] [Abstract][Full Text] [Related]
22. [Downregulation of p57kip2 is involved in the proliferation of vascular smooth muscle cell (VSMC)].
Nakano N
Hokkaido Igaku Zasshi; 2001 Mar; 76(2):93-100. PubMed ID: 11344906
[No Abstract] [Full Text] [Related]
23. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
[TBL] [Abstract][Full Text] [Related]
24. Density-dependent shift of transforming growth factor-beta-1 from inhibition to stimulation of vascular smooth muscle cell growth is based on unconventional regulation of proliferation, apoptosis and contact inhibition.
Hneino M; Bouazza L; Bricca G; Li JY; Langlois D
J Vasc Res; 2009; 46(2):85-97. PubMed ID: 18596377
[TBL] [Abstract][Full Text] [Related]
25. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
Lu Z; Hunter T
Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.
Kudo Y; Kitajima S; Ogawa I; Miyauchi M; Takata T
Oral Oncol; 2005 Feb; 41(2):105-16. PubMed ID: 15695111
[TBL] [Abstract][Full Text] [Related]
29. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
[TBL] [Abstract][Full Text] [Related]
30. The Ets transcription factor GABP is required for cell-cycle progression.
Yang ZF; Mott S; Rosmarin AG
Nat Cell Biol; 2007 Mar; 9(3):339-46. PubMed ID: 17277770
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
[TBL] [Abstract][Full Text] [Related]
32. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
[TBL] [Abstract][Full Text] [Related]
33. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70.
Zou P; Yoshihara H; Hosokawa K; Tai I; Shinmyozu K; Tsukahara F; Maru Y; Nakayama K; Nakayama KI; Suda T
Cell Stem Cell; 2011 Sep; 9(3):247-61. PubMed ID: 21885020
[TBL] [Abstract][Full Text] [Related]
34. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression.
Chen J; Guerriero E; Lathrop K; SundarRaj N
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):175-83. PubMed ID: 18172090
[TBL] [Abstract][Full Text] [Related]
35. p57(Kip2) and cancer: time for a critical appraisal.
Borriello A; Caldarelli I; Bencivenga D; Criscuolo M; Cucciolla V; Tramontano A; Oliva A; Perrotta S; Della Ragione F
Mol Cancer Res; 2011 Oct; 9(10):1269-84. PubMed ID: 21816904
[TBL] [Abstract][Full Text] [Related]
36. Development of mice without Cip/Kip CDK inhibitors.
Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
[TBL] [Abstract][Full Text] [Related]
37. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
38. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
39. Cell cycle regulation in the inner ear sensory epithelia: role of cyclin D1 and cyclin-dependent kinase inhibitors.
Laine H; Sulg M; Kirjavainen A; Pirvola U
Dev Biol; 2010 Jan; 337(1):134-46. PubMed ID: 19854167
[TBL] [Abstract][Full Text] [Related]
40. Raphanus sativus and its isothiocyanates inhibit vascular smooth muscle cells proliferation and induce G(1) cell cycle arrest.
Suh SJ; Moon SK; Kim CH
Int Immunopharmacol; 2006 May; 6(5):854-61. PubMed ID: 16546717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]